7 employees
PhotoPharmics is a clinical-stage medical device company developing next-generation treatments for treating neurodegenerative disorders.
2011
$2.1M
from 2 investors over 2 rounds
PhotoPharmics, Inc raised undisclosed on January 6, 2022
Investors: Kickstart Seed Fund
PhotoPharmics, Inc raised $2.1M on December 27, 2012